Fresenius Medical Care stock at EUR 39.35, up 0.79% before Xetra
Published on 11/04/2026 at 08:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSFresenius Medical Care faces tighter outlook
- Third-quarter revenue remained broadly stable, while operating income came under regulatory and inflation pressure.
- The company narrowed its 2026 operating-income outlook to a range from flat growth to a mid-single-digit decline.
- Investors are also watching US treatment volumes and the rollout of the 5008X CAREsystem.
The real-time quote of Fresenius Medical Care stock traded at EUR 39.35 on Lang & Schwarz at 08:04 CET on Wednesday, November 4, 2026, 0.79 percent above the Xetra close of Tuesday, November 3, at EUR 39.04.
Third-quarter pressure narrows outlook
Fresenius Medical Care reported broadly stable third-quarter revenue, but regulatory and inflation pressures weighed on operating income. The company narrowed its 2026 operating-income outlook to between flat growth and a mid-single-digit percentage decline.
Management is also focusing on US treatment volumes and the rollout of the 5008X CAREsystem. The business remains exposed to reimbursement trends, inflation and the pace of growth in its largest market.
Global markets are setting the broader backdrop for healthcare stocks as investors assess earnings, interest rates and sector risk.
